ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 175 filers reported holding ANI PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $58 | +7.4% | 1 | 0.0% | 0.00% | – |
Q2 2023 | $54 | +35.0% | 1 | 0.0% | 0.00% | – |
Q1 2023 | $40 | 0.0% | 1 | 0.0% | 0.00% | – |
Q4 2022 | $40 | – | 1 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 1 | -99.8% | 0.00% | – |
Q4 2019 | $25,000 | -26.5% | 401 | -13.9% | 0.00% | -100.0% |
Q3 2019 | $34,000 | -24.4% | 466 | -14.3% | 0.00% | 0.0% |
Q2 2019 | $45,000 | +18.4% | 544 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $38,000 | +52.0% | 544 | -0.2% | 0.00% | – |
Q4 2018 | $25,000 | -21.9% | 545 | -3.9% | 0.00% | -100.0% |
Q3 2018 | $32,000 | -22.0% | 567 | -7.4% | 0.00% | 0.0% |
Q2 2018 | $41,000 | +20.6% | 612 | +6.1% | 0.00% | 0.0% |
Q1 2018 | $34,000 | – | 577 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |